[Atherosclerosis, alcohol and diabetes].

Area of Science:

• Cardiovascular Science
• Metabolic Disorders
• Pharmacology

Background:

• Diabetes mellitus is a significant risk factor for atherosclerosis, contributing to cardiovascular morbidity and mortality.
• Moderate alcohol consumption has been linked to reduced cardiovascular disease (CVD) risk.
• Understanding the interplay between alcohol, diabetes, and CVD is crucial for public health.

Purpose of the Study:

• To review the mechanisms behind alcohol's anti-atherogenic effects.
• To examine data on moderate alcohol consumption's role in preventing cardiovascular diseases, particularly in diabetic individuals.
• To assess the potential benefits and risks of alcohol consumption for diabetic patients.

Main Methods:

• Literature review of studies on alcohol metabolism and cardiovascular effects.
• Analysis of research on polyphenols, acetaldehyde, and their impact on atherosclerosis markers.
• Evaluation of clinical data regarding moderate alcohol intake and cardiovascular outcomes in diabetic populations.

Main Results:

• Alcohol metabolism, particularly the formation of acetaldehyde, can inhibit advanced glycation endproducts (AGE) and lipoprotein oxidation, key factors in atherosclerosis.
• Red wine polyphenols possess antioxidant properties that may contribute to cardiovascular protection.
• Moderate alcohol consumption shows potential for reducing cardiovascular morbidity and mortality.

Conclusions:

• Moderate alcohol consumption may offer cardiovascular benefits by mitigating atherogenic processes.
• Diabetic patients might benefit from moderate alcohol intake, but careful consideration of hypoglycemia risk is essential.
• Further research is warranted to precisely define safe consumption levels and mechanisms in diabetic individuals.